Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 trial of once-weekly BAY 79-4980 prophylaxis versus once-weekly or on-demand Kogenate Bayer in severe hemophilia A
2006-004458-26Phase 3Completed
- Sponsor
- Bayer
- Start
- Nov 2006
- Modality
- Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of BAY 79-4980 and Factor VIII in hemophilia A (3 arms), sponsored by Bayer. Started Nov 2006; status: completed.
02
Drugs
BAY 79-4980Factor VIII
03
Conditions
hemophilia A
Beyond the preview
Go deeper on 2006-004458-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-004458-26.